Business Context and Reporting Period
This Form 8-K is a current report filed by Enochian Biosciences, Inc. (not Lunai Bioworks Inc.) on November 22, 2019. The registrant is a Delaware corporation with its principal executive offices in Los Angeles, CA. Its common stock trades on The Nasdaq Stock Market LLC under the symbol ENOB.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the departure of a director:
- Resignation: William A. Haselstine, PhD, resigned as a member of the Board of Directors effective immediately on November 22, 2019.
- Reason: The resignation was due to recent developments outside the control of the Board requiring an increased time commitment for his service. The filing explicitly states the departure was not due to any disagreement with the Company, the Board, management, or the policies or practices of the Company.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks, contingencies, or unusual items related to operations or finances were disclosed in this report.
Investor Verification Checklist
- Verify the correct company name is Enochian Biosciences, Inc. (Ticker: ENOB), as the request metadata referenced "Lunai Bioworks Inc."
- Confirm the current composition of the Board of Directors following Dr. Haselstine's immediate resignation.
- Review subsequent filings for any financial updates, as this 8-K contains no financial data.